The first two mononuclear manganese citrate complexes, (NH4)4[MnII(C6H5O7)2] (1) and (NH4)5[MnIII(C6H4O7)2].2H2O (2) were synthesized in aqueous solutions near physiological pH values. They were isolated in their pure crystalline forms and characterized by elemental analyses and spectroscopic techniques, including UV/visible, electron paramagnetic resonance, Fourier transformed infrared, and magnetic susceptibility measurements. Compound 1 crystallizes in the monoclinic space group P2(1)/c, with a = 8.777(1) A, b = 13.656(3) A, c = 9.162(2) A, beta = 113.62(2) degrees, V = 1006.2(6) A3, and Z = 2. Compound 2 crystallizes in the triclinic space group P1, with a = 9.606(3) A, b = 9.914(3) A, c = 7.247(3) A, alpha = 91.05(1) degrees, beta = 105.60(1) degrees, gamma = 119.16(1) degrees, V = 571.3(3) A3, and Z = 1. The X-ray crystal structures of 1 and 2 revealed that, in both cases, the manganese ion is six-coordinate and is bound by two citrate ligands in a distorted octahedral fashion. In the case of complex 1, the citrate ion binds to Mn2+ as a triply deprotonated ligand, retaining the central carbon hydroxyl hydrogen, whereas, in the case of compound 2, the citrate ligand coordinates to Mn3+ as a fully deprotonated entity. Compound 2 contains water molecules of crystallization in the unit cell which, through extensive hydrogen-bonding interactions, bestow considerable stability upon the Mn(3+)-citrate assembly. There are significant contributions to the stabilities of the assembled lattices in 1 and 2 arising from the ammonium counterions neutralizing the high anionic charges of the complexes. The EPR spectra attest to the presence of paramagnetic Mn2+ and Mn3+ species in the solid state. Corroborative evidence is obtained from the magnetic susceptibility measurements in the range 5-300 K. Complexes 1 and 2 present clear cases of mononuclear manganese citrate species relevant to manganese speciation in biological media and potentially related to the beneficial as well as toxic effects of manganese on humans.

The involvement of Cd(II) in toxic manifestations and pathological aberrations in lower and higher organisms entails interactions with low and high molecular mass biological targets. To understand the relevant chemistry in aqueous media, we have launched pH-dependent synthetic efforts targeting Cd(II) with the physiological ligand citric acid. Reactions of Cd(II) with citric acid upon the addition of NaOH at pH 2.5 and pyridine at pH 3 and the addition of ammonia at pH approximately 7 led to the new complexes [Cd3(C6H5O7)2(H2O)5] x H2O (1) and (NH4)[Cd(C6H5O7)(H2O)] x H2O (2), respectively. Complexes 1 and 2 were characterized by elemental analysis, spectroscopy (FT-IR and NMR), and X-ray crystallography. Complex 1 crystallizes in the monoclinic space group P2(1)/n, with a = 18.035(6) A, b = 10.279(4) A, c = 12.565(4) A, beta = 109.02(1) degrees, V = 2202(2) A3, and Z = 4. Complex 2 crystallizes in the monoclinic space group P2(1), with a = 9.686(4) A, b = 8.484(4) A, c = 7.035(3) A, beta = 110.28(1) degrees, V = 542.3(4) A3, and Z = 2. Complex 1 is a trinuclear assembly with the citrate ligand securing a stable metallacyclic ring around one Cd(II), with the terminal carboxylates spanning into the coordination sphere of two nearby Cd(II) ions. Complex 2 contains mononuclear units of Cd(II) bound by citrate in an overall coordination number of 8. In both 1 and 2, the participating citrates exhibit three different modes of coordination, thus projecting a distinct yet variable aqueous structural chemistry of Cd(II) with physiological substrates. The pH-dependent chemistry and its apparent structural diversity validate past solution speciation studies, projecting the existence of mononuclear species such as the one in the anion of 2. The spectroscopic and structural properties of 2 emphasize the significance of the information emerging from synthetic studies that otherwise would not have been revealed through conventional solution studies, while concurrently shedding light onto the linkage of the requisite chemistry with the potential biological toxicity of Cd(II).